NEWDEAL HALLU LOCK PLATE SYSTEM
K083154 · Newdeal Sas · HRS · Jul 10, 2009 · Orthopedic
Device Facts
| Record ID | K083154 |
| Device Name | NEWDEAL HALLU LOCK PLATE SYSTEM |
| Applicant | Newdeal Sas |
| Product Code | HRS · Orthopedic |
| Decision Date | Jul 10, 2009 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 888.3030 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The HALLU® Lock Plate System is intended to be implanted for fixation of fractures, osteotomies or arthordesis of the first metatarso-phalangeal joint, including cases of : - Hallux rigidus - Severe hallux valgus (IM angle >20° and HV angle > 40°) - - Deformity from rheumatoid arthritis - - Failed previous surgical procedure - - Traumatic arthritis - -Neuromuscular instability. Addition of a Newdeal® QWIX® screw crossing the joint is strongly recommended for optimal arthrodesis consolidation. HALLU® Lock Newdeal® plates must be fixed with the Surfix® fixed angle locking system and with the Surfix® -Alpha variable angle locking system of 2.7mm or 3.0mm diameter (screws and lock-screws).
Device Story
Low-profile titanium bone fixation plate system; used for first metatarso-phalangeal (MTP) joint arthrodesis, osteotomies, or fracture fixation. Plates are pre-bent (10° valgus/dorsiflexion) with options for further intraoperative anatomical contouring. Fixation achieved via SURFIX (fixed angle) and SURFIX ALPHA (variable angle) locking screws (2.7mm or 3.0mm). Recommended use includes an additional QWIX screw crossing the joint to enhance arthrodesis consolidation. Device is implanted by orthopedic surgeons in a clinical/surgical setting. Provides mechanical stability to the MTP joint to facilitate bone healing and correct deformities.
Clinical Evidence
Bench testing only; no clinical data provided. Mechanical testing confirmed that the modified HALLU® Lock Plate System possesses mechanical properties equivalent to the predicate device.
Technological Characteristics
Low-profile titanium bone fixation plates. Features pre-bent geometry (10° valgus/dorsiflexion). Fixation via SURFIX (fixed angle) and SURFIX ALPHA (variable angle) locking screws (2.7mm or 3.0mm diameter).
Indications for Use
Indicated for fixation of fractures, osteotomies, or arthrodesis of the first metatarso-phalangeal joint in patients with hallux rigidus, severe hallux valgus (IM angle >20°, HV angle >40°), rheumatoid arthritis deformity, failed previous surgery, traumatic arthritis, or neuromuscular instability.
Regulatory Classification
Identification
Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.
Predicate Devices
- HALLU® Plate System (K021626)
Related Devices
- K093781 — MODIFIED: NEWDEAL HALLU PLATES · Newdeal Sas · Jan 22, 2010
- K021626 — HALLU PLATES · New Deal, S.A. · Aug 12, 2002
- K210534 — GEO FirstFUSE 1st MTP Joint Arthrodesis Plating System · Gramercy Extremity Orthopedics, LLC · Mar 26, 2021
- K200108 — GEO 1st MTP Joint Arthrodesis Plating System · Gramercy Extremity Orthopedics, LLC · Mar 26, 2020
- K190670 — ORTHOLOC 2 Lapidus with Rotation System · Wrightmedicaltechnologyinc · May 14, 2019
Submission Summary (Full Text)
{0}------------------------------------------------
K083154 1/2
Image /page/0/Picture/1 description: The image shows the logo for "newdeal", which is written in a stylized font. To the left of the word is a circle with four dots around it. Below the word "newdeal" is the text "An Integra LifeSciences Company".
## 510(K) SUMMARY
# Newdeal HALLU® Lock Plate System
JUL 1,0 2009
## Submitter's name and address:
Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52
### Contact person and telephone number
Morgane Grenier Director of Regulatory and Clinical Affairs - EMEA Newdeal SAS 10, place d'Helvétie 69006 Lyon, France Tel: +33 4 37 47 51 51 Fax: +33 4 37 47 51 52
### Alternate Contacts Authorized Agent in the United States
Judith E. O'Grady, RN, MSN Sr. Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536, USA Tel: (609) 936-2311 Fax: (609) 275-9445 E-mail: jogrady@integra-ls.com
### Date Summary was prepared:
July 7, 2009
### Name of the device:
| Proprietary Name: | Newdeal HALLU® Lock Plate System |
|-----------------------|----------------------------------------------------------------------------------------------|
| Common Name: | Plate, Fixation, Bone |
| Classification Name: | Single/multiple component metallic bone fixation appliances and accessories (21CFR 888.3030) |
| Device Product Code: | HRS |
| Classification Panel: | Orthopedic |
{1}------------------------------------------------
### Substantial Equivalence:
The modified HALLU® Lock Plate System is substantially equivalent to commercially marketed device, HALLU® Plate System, K021626
#### Device Description:
The Newdeal HALLU® Lock Plate System is a low profile Titanium plate dedicated to first metatarso-phalangeal arthrodesis. The HALLU Lock C plates are pre-bent with 10° valgus and 10° dorsiflexion. The HALLU Lock S plates are available with 10° valgus and 10° or 5° dorsiflexion. Pre-operative bending is possible to completely fit to the anatomical shape of the joint. Their fixation is provided by SURFIX and SURFIX ALPHA locking screws.
### Intended Use:
The HALLU® Lock Plate System is intended to be implanted for fixation of fractures, osteotomies or arthordesis of the first metatarso-phalangeal joint, including cases of :
- Hallux rigidus
- Severe hallux valgus (IM angle >20° and HV angle > 40°) -
- Deformity from rheumatoid arthritis -
- Failed previous surgical procedure -
- Traumatic arthritis -
- -Neuromuscular instability.
Addition of a Newdeal® QWIX® screw crossing the joint is strongly recommended for optimal arthrodesis consolidation.
HALLU® Lock Newdeal® plates must be fixed with the Surfix® fixed angle locking system and with the Surfix® -Alpha variable angle locking system of 2.7mm or 3.0mm diameter (screws and lock-screws).
#### Testing and Test Results:
Mechanical tests have been carried out. Results have shown that the mechanical properties of the modified HALLU® Lock Plate System are equivalent to the properties of the unmodified device, HALLU® Plates, K021626.
#### Conclusion
The modified HALLU® Lock Plate System is substantially equivalent to commercially marketed device, HALLU® Plates, K021626.
The modifications do not change the intended use or fundamental scientific technology of the device and do not raise any new issues of safety or effectiveness.
KOR 3124
{2}------------------------------------------------
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States of America. The seal features a stylized eagle with three stripes forming its body and wing. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES . USA" are arranged in a circular pattern around the eagle.
#### Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Newdeal SAS % Ms. Judith O'Grady Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536
1.0 2009
Re: K083154
Trade/Device Name: HALLU Lock Plates Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS. HWC
Dated: June 10, 2009 Received: June 11, 2009
Dear Ms. O'Grady:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2 - Ms. Judith O'Grady
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/cdrh/comp/ for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Halvare Queim
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) Number (if known): K 083 | 54
Device Name: HALLU® Lock Plates
Indications For Use:
-
The HALLU® Lock Plates are intended for fixation of fractures, osteotomies or arthrodesis of the first metatarso-phalangeal joint. Including cases of:
- Hallux rigidus -
- Severe hallux valgus (IM angle >20° and HV angle >40°) -
- Deformity from rheumatoid arthritis -
- Failed previous surgical procedure -
- Traumatic arthritis
- Neuromuscular instability.
The HALLU® Lock plates must be fixed with the SURFIX® fixed angle locking system and with the SURFTX®-Alpha variable angle locking system of 2.7mm or 3.0mm diameter (screws and lock-screws).
Addition of a Newdeal® QWIX® screw crossing the joint is strongly recommended for optimal arthrodesis consolidation
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Kuta
(Division Sign-Off)
Division of Surgical, Orthopedic,
and Restorative Devices
510(k) Number
Attachment B1 - Page 1 of 1